Pirelli: a Video Illustrating 11 Years of Annual Reports

MILAN, Italy, March 13, 2023 (GLOBE NEWSWIRE) — Financial statements that can be leafed through like art books. Since 2010, Pirelli’s annual report has changed guise, becoming a publication enriched by the contribution of personalities from the world of art and culture from all over the world. A brand storytelling project that, for the past 11 years, has used essays, images and artwork to tell the story of the company, going beyond the figures, in line with a tradition that has always seen Pirelli at the forefront in promoting its corporate culture with innovative forms of communication.
Cartoonists, writers, street artists, scriptwriters, calligraphers, musicians, philosophers, ceramists and illustrators alike have enriched the company’s annual reports over the years: artists with different backgrounds, nationalities and generations who have portrayed the company’s soul in original and unique ways. An artistic journey illustrated in the video ’11 Years of Pirelli Annual Reports,’ a visual summary of the works, texts and graphics that have been featured in Pirelli’s annual reports from 2010 to 2021, while waiting to discover the creative approach that will be used in the 2022 annual report.

The first creative project linked to Pirelli’s annual report, in 2010, saw the involvement of photography students from NABA (New Academy of Fine Arts) in Milan, who were called upon to interpret a theme that has become increasingly relevant over time, that of sustainability. Then, in 2011, it was the turn of designer Stefan Glerum, who interpreted the values of Pirelli: reliability, flexibility, speed, technology and innovation. In 2012, it was the turn of New Yorker cartoonist Liza Donnelly, who interpreted in graphic form the ten words chosen by university students from around the world on the most significant values for their future. The 2013 annual report saw writer and screenwriter Hanif Kureishi coordinate 10 young international talents in reworking the concept of the wheel in the project ‘Spinning the Wheel.’ In 2014, street art was showcased with works by the Brazilian Marina Zumi, the German Dome and the Russian Alexey Luka, focusing on themes such as the street, mobility and multiculturalism. The following year, in 2015, Pirelli called Russian artist Pokras Lampas, an exponent of modern calligraphy, to represent the value of uniqueness – hence the title of the publication: ‘Every Mark is Unique’ – through handwriting and fingerprints; the report also included the text ‘Like the sentinel moon’ by writer Javier Marias. The 2017 ‘Data Meets Passion’ annual report described Pirelli’s digital transformation, illustrated by the artist Emiliano Ponzi and with the contribution of three internationally renowned writers: Mohsin Hamid, Tom McCarthy and Ted Chiang. In 2018, the annual report was dedicated to 25 years of ‘Power is Nothing Without Control,’ with images evocative of the pay-off that identifies Pirelli around the world and texts by three internationally renowned authors: Adam Greenfield, Lisa Halliday and J.R. Moehringer. In 2019, resilience was the central theme of ‘The Road Ahead,’ with unpublished texts by writer Emmanuel Carrère and essayist John Seabrook, and illustrations by visual artist Selman Hoşgör. ‘The Human Dimension’ was the title of the 2020 annual report, in which three authors – Luciano Floridi, Michele Masneri and Jia Tolentino – reflected on the importance of human capital and the impacts that technological and social transformations have on people. Finally, in 2021, several internationally renowned artists – Giovanni Mengoni, Tu Yonghong, Lisette Correa, Brazilian Art Collective and Andrei Cavassi – created works of art inspired by the sounds, colours and atmospheres of five Pirelli factories around the world, accompanied by original texts by the theologian and philosopher Vito Mancuso and writer Nadia Owusu.

For more information:

Press Office LaPresse – ufficio.stampa@lapresse.it

LINK VIDEO: https://we.tl/t-S1my8tg94A

GlobeNewswire Distribution ID 8786974

PharmaLedger Association Launches Digital Trust Ecosystem in Healthcare

photo PharmaLedger video release link

original image of PharmaLedger event and link to video release

BASEL, Switzerland, March 13, 2023 (GLOBE NEWSWIRE) — The PharmaLedger Association™ (PLA), a not-for-profit based in Switzerland, announces the endorsement of its 3-year strategic plan to implement and promote a Digital Trust Ecosystem in healthcare (DTE-H) at its Annual General Meeting held in Lucerne, Switzerland on 1 March 2023. The member organizations also confirmed the appointment of eight Directors to its board, delivering on PLA’s core value of “Ecosystem Leadership.”

Representing the diversity of healthcare, PLA’s founding members comprise of large and small pharmaceutical companies, research organizations, patient representative organizations, non-profit organizations, technology, and healthcare service providers. PLA has confirmed its mandate as a pre-competition umbrella organization delivering common and interoperable digital solutions in the areas of Product TrustDecentralized Clinical Trials, and Supply Chain Traceability.

  • Products & Project: In Q1 2023, PLA will release the first qualified product, electronic Product Information for implementation by its members.
    In Q2 2023, the Association will continue with the development of new products in its innovation xLab, including of a product digital twin, decentralized identities, and verifiable credentials to facilitate visibility, security, traceability, and trust in all areas of healthcare.
  • Governance & Compliance: PLA will leverage its capability to develop, qualify, launch, and maintain products in healthcare’s highly regulated environment by ensuring continuous adherence to antitrust, intellectual property, data privacy, and Computerized System Assurance guidelines.
  • Ecosystem Engagement & Growth: The association will continue to onboard new members and engage with authorities, trade associations and standards development organizations, ensuring growth and financial viability.
  • Platform Technology & Security: PLA will focus on easing adoption of new solutions with its members and users while maintaining the cybersecurity benefits of its architecture.

The formation of PLA and the endorsement of its mission by diverse members of healthcare is a major milestone. This paves the way for delivery of widely trusted blockchain-based platforms with new open-source healthcare solutions to create value for patients and ecosystem stakeholders. PLA is grateful to its 20 founding members and invites all healthcare related organizations to learn more and engage towards the realization of a trusted Healthcare 4.0.

“Blockchain is a team sport. PLA has started with a diverse and strong team of members with a common vision and who believe in real change. With PLA we have the right vehicle, resources, and roadmap to take patients to a better place in healthcare,” Daniel Fritz, Executive Director, PharmaLedger Association.


PLA is the result of the successful completion of the PharmaLedger research project, a €22 million, 30-member consortium with 12 large pharma companies and 18 public partners, funded under the European Union (EU) and European Federation of Pharmaceutical Industries and Associations (EFPIA)’s Innovative Health Initiative.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0682572a-b8ac-4b5b-885b-8af008287cff

Contact – info@pharmaledger.org / www.pharmaledger.org

GlobeNewswire Distribution ID 1000797758

Oxford Population Health and SomaLogic deliver 28 million proteomic data points on China Kadoorie Biobank samples

BOULDER, Colo., March 13, 2023 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in proteomics technology, recently completed the 7,000-plex assay on and delivered data for 4,000 plasma samples from the China Kadoorie Biobank (CKB), one of the world’s largest prospective studies. The SomaLogic team provided more than 28 million data points from the assay which will be combined with other available genetic, lifestyle, anthropometric and health outcome data to address a range of research questions. This work builds on a successful history of SomaScan® Platform utilization in some of the world’s largest population proteomics biobank projects, including the EPICMESA, Fenland, Whitehall II, HUNT3, CRIC, COPD Gene, Spiromics, deCODE and ARIC datasets.

Professor Zhengming Chen, Richard Peto Professor of Epidemiology at Oxford Population Health and UK-Principal Investigator of the China Kadoorie Biobank, said “The large-scale application of proteomics assays in big population biobanks such as CKB will be a game changer. Building on the experience gained in these initial 4,000 samples, we will seek to extend the use of the proteomic assay to a much larger number of samples in the near future.”

The China Kadoorie Biobank (www.ckbiobank.org) was established to investigate the main genetic and environmental causes of common chronic diseases in the Chinese population. Between 2004 and 2008, over 510,000 adults were recruited from ten geographically defined regions of China, with extensive data collection by questionnaire and physical measurements, and with long-term storage of blood samples for future study. All participants are now being monitored for fatal and non-fatal health outcomes through linkage with established registries and health insurance databases in the study areas.

This large, well-established study will be a uniquely powerful and rich resource for investigating the main causes of many common chronic diseases over the next few decades, and the information generated has the potential to improve understanding of disease etiology, risk prediction and development of new treatments. The project is a long-term collaboration between Oxford Population Health, Peking University and the Chinese Academy of Medical Sciences.

SomaLogic’s proprietary SomaScan Platform is designed to be a universal platform that can be applied across research and discovery, translational research and biopharmaceutical development, and clinical applications. SomaLogic can run approximately 7,000 protein measurements on a single 55 microliter plasma or serum sample. The company has run more than 550,000 samples to date.

About SomaLogic 
SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s personalized measurement of important changes in an individual’s proteins over time. For more information, visit www.somalogic.com .

About Oxford Population Health
Oxford Population Health (the Nuffield Department of Population Health) is a world-leading research institute, based at the University of Oxford, that investigates the causes and prevention of disease.

We have over 750 staff, students and academic visitors working in a number of world-renowned population health research groups, including the Cancer Epidemiology Unit (CEU), Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), and the National Perinatal Epidemiology Unit (NPEU), and other groups working on public health, health economics, ethics and health record linkage. Oxford Population Health is also a key partner in the Oxford University Big Data Institute.


Forward Looking Statements Disclaimer
This press release contains certain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. All statements, other than statements of historical fact included in this press release, regarding our strategy, future operations, financial position, estimated revenues, projections, prospects, plans and objectives of management are forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “forecast,” “guidance,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “continue,” “will likely result,” “possible,” “potential,” “predict,” “pursue,” “target” and similar expressions, although not all forward-looking statements contain such identifying words. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward-looking statements do not guarantee future performance and involve known and unknown risks, uncertainties and other factors.   Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including factors which are beyond SomaLogic’s control. You should carefully consider these risks and uncertainties, including, but not limited to, those factors described under Part I, Item 1A – “Risk Factors” in our Annual Report on Form 10-K and other filings we make with the Securities and Exchange Commission. These filings identify and address important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and SomaLogic assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The Company will not and does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Media Contact
Emilia Costales

Investor Contacts
Lauren Glaser

Marissa Bych
Gilmartin Group LLC

GlobeNewswire Distribution ID 8786241

ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep

  • 81% of respondents experience one or more symptoms indicating poor sleep quality, despite 64% saying they’re satisfied with the quantity of their sleep
  • Women and older generations are less satisfied with the quality and quantity of their sleep compared to the survey’s overall average
  • Annual survey aims to raise awareness for sleep health during National Sleep Awareness Week and World Sleep Day

SAN DIEGO, March 13, 2023 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) announced today the results from its 2023 Global Sleep Survey in conjunction with National Sleep Awareness Week (March 12-18) and World Sleep Day (March 17) to raise awareness for the importance of sleep as a key component of physical and mental health.

The survey found that despite 64% of respondents saying they are satisfied with the quantity of their sleep, more than 80% report experiencing symptoms of disruption related to their sleep quality, with consumers most commonly reporting mood changes, such as depression or irritability (33%), waking up with a dry mouth or sore throat (30%), difficulty concentrating during the day (30%), and excessive daytime sleepiness (29%).

The 2023 Global Sleep Survey asked more than 20,000 respondents from 12 countries during January 2023 about the quantity and quality of their sleep, bedtime routines, and sleep habits and found differences in respondents’ quantity and quality of sleep based on location, gender, and age:

  • Respondents from India (84%), Mexico (69%), and China (66%) are most satisfied with their quantity of sleep, while those in Australia (47%), Japan (46%), and the UK (45%) are the least satisfied with the quantity of their sleep.
  • 8 in 10 respondents reported one or more symptoms of sleep disruption related to sleep quality; Mexico (87%), France (87%), and South Korea (85%) had the highest rates of reported symptoms, while Japan (60%) had the lowest.
  • 60% of women report being satisfied with their quantity of sleep (the least of any gender), compared to 68% of men and 65% of nonbinary respondents. Women (83%) and nonbinary (94%) respondents were more likely to say they have at least one symptom of poor sleep compared to men (79%).
  • 52% of women report regularly waking up with a negative feeling in the morning (e.g. cranky, anxious, miserable), with 26% saying they’re still tired. Conversely, 58% of men report they are more likely to wake up feeling positive (e.g. happy, refreshed, calm, energetic).
  • 43% of Gen Xers and Boomers and 49% of the Silent Generation report that they aren’t satisfied with the quality of their sleep, compared to only 37% of Millennials and 31% of Gen Zers.

Despite a majority of survey respondents reporting they wake up with symptoms of poor sleep quality – one-third (33%) of respondents have not been tested for sleep apnea or sought medical help for other sleep conditions because they do not believe they have sleep-related medical conditions. Additionally, 49% of respondents said their doctor has never asked them proactively about their sleep quality.

“Prioritizing sleep is one of the most effective ways to improve your health, and poor sleep can increase the risk of diabetes, obesity, heart disease, and depression,” said Carlos M. Nunez, M.D., chief medical officer for ResMed. “It’s critical to have an honest discussion with your healthcare provider about your sleep habits and seek help if you’re experiencing patterns or symptoms of poor sleep as it could point to a more concerning health issue or sleep disorder such as sleep apnea.”

What’s Keeping People Up at Night and Tools They’re Using to Improve Their Sleep
Additional findings of ResMed’s 2023 Global Sleep Survey address what’s keeping people up at night and how people use technology to improve sleep. Findings include:

  • Amidst global reports of potential economic instability, anxiety/depression (33%) and work-related concerns (33%) are the two most cited reasons for keeping people up at night – an increase compared to a similar question asked in 2022 (29% and 22%, respectively).
  • Anxiety/depression was most commonly reported as the reason keeping people up at night in Brazil (46%), the U.S. (45%), Australia (42%), and the UK (42%) – and least reported in Japan (24%), India (22%), and Germany (21%).
  • Among consumers whose sleep has gotten worse over the past year, nearly one-third say financial pressures have caused the decline in their sleep quality (32%), with those in the U.S. (41%), Mexico (39%), and India (37%) reporting the highest impact.
  • 43% of Millennials report using a sleep tracker to keep records of their sleep patterns and quality of sleep, higher than Gen Z (35%), Gen X (28%), Boomers (15%), and the Silent Generation (7%).

To learn more about ResMed’s 2023 Global Sleep Survey or to take a quick self-assessment for your risk of sleep apnea, visit SleepForBetterTomorrow.com. Plus, learn about the digital health technologies that are transforming how we sleep, breathe, live, and care for patients on ResMed’s new podcast series, Awaken Your Best, hosted by Dr. Nunez and available anywhere you stream your favorite podcasts including on Spotify and Apple Podcasts. The first episode premiers today – Monday, March 13 – featuring a conversation on the latest digital health trends with Gary Shapiro, acclaimed author and president and CEO of the Consumer Technology Association.

Survey Methodology
ResMed 2023 Global Sleep Survey included 20,069 total participants across the United States, the United Kingdom, Germany, France, South Korea, Mexico, Japan, Singapore, Australia, Brazil, China, and India, conducted in January 2023.

For generational comparisons, the survey defines Gen Z as ages 18-26, Millennials ages 27-42, Gen X ages 43-58, Baby Boomers ages 59-77, and the Silent Generation ages 78-95.

About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies” and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

For media For investors
Kristin Deuber Amy Wakeham
+1 614.975.4186 +1 858.836.5000
resmed@allisonpr.com investorrelations@resmed.com

GlobeNewswire Distribution ID 8786245

Philips appoints Julia Strandberg as Chief Business Leader of the Connected Care businesses

March 13, 2023

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Julia Strandberg as the Chief Business Leader of its Connected Care businesses, effective April 24, 2023. Ms. Strandberg will become a member of Philips’ Executive Committee reporting to Philips CEO Roy Jakobs. As of April 1, 2023, Philips’ Connected Care businesses will comprise the Monitoring, Sleep & Respiratory Care and Enterprise Informatics businesses.

Ms. Strandberg (American, 1974) joins Philips from Pear Therapeutics, where she served as the Chief Commercial Officer leading the commercial team that built, launched and grew their prescription digital therapeutics offering. Prior to this, Ms. Strandberg led a healthcare business consulting firm focused on driving client growth, and before this, she led Medtronic’s global Health Informatics and Monitoring business, and was the global marketing leader for the Patient Monitoring business within Covidien’s Respiratory & Monitoring group, which was acquired by Medtronic. Ms. Strandberg started her career at 3M, where she worked across a number of roles at the company.

“On behalf of Philips’ Executive Committee, I am delighted to announce that Julia Strandberg will join Philips as our new Chief Business Leader of the Connected Care businesses and member of the Executive Committee,” said Roy Jakobs, CEO of Royal Philips. “Julia brings deep, multi-disciplinary expertise, including in informatics and monitoring, to Philips. Passionate about improving the healthcare experience for patients and providers across care settings, Julia understands how to deliver in the global healthcare ecosystem and adds extensive experience in developing and commercializing medical technologies.”

Ms. Strandberg succeeds Dan Leonard, who took on the role of Chief Business Leader Connected Care ad interim when Roy Jakobs became CEO in October, 2022.

Philips’ strong brand and compelling purpose appeal to and attract talent, and the company has therefore continued to strengthen the organization with new health technology talent, including seasoned leaders with deep expertise. Ms. Strandberg ’s appointment to Philips’ Executive Committee builds on the recent appointments of Wim Appelo as Philips’ Chief Operations Officer and Steve C. de Baca as Philips’ Chief Patient Safety & Quality Officer, as well as the promotion of Jeff DiLullo to Philips’ Chief Market Leader of North America.

Additional information on Philips’ Executive Committee can be found here.

For further information, please contact:

Ben Zwirs
Philips Global Press Office
Tel.: +31 615213446
E-mail: ben.zwirs@philips.com

Derya Guzel
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: derya.guzel@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Forward-looking statements
This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.


GlobeNewswire Distribution ID 1000797685

AFM has initiated an investigation into irregularities in trading of Azerion shares

Amsterdam, 13 March 2023 – Today Azerion has announced an investigation by the Autoriteit Financiële Markten (AFM), which according to AFM-information known to the Company, appears to be related to compliance with article 15 of the Market Abuse Regulation and seems to be focused on the shareholders of Principion Holding B.V., including Azerion co-CEOs Atilla Aytekin and Umut Akpinar. Principion is Azerion’s largest shareholder.

Based on the information available and the information provided by co-CEO Atilla Aytekin, he decided, in close consultation with the Supervisory Board, that the interests of the Company and its stakeholders are best served by him temporarily stepping aside at this moment in time from his duties and responsibilities as co-CEO of the Company.

The operational leadership of the Company remains with Azerion’s Executive Committee and broader leadership team, with Umut Akpinar as CEO and Ben Davey as CFO. This is a continuation of the current day-to-day practice for organic and inorganic activities. The team remains focused on fulfilling Azerion’s strategy and dedicated execution of the business plan.

The AFM approached Azerion on Tuesday 7 March 2023 to obtain information. The Company is fully available to answer any questions of the AFM.

The Supervisory Board has installed a Special Committee to steer the process and to be kept fully informed.

The Company is limited in its possibilities to provide further information pending the investigation, and will share information if and when appropriate.

About Azerion
Azerion is a high-growth digital entertainment and media platform. As a content-driven, technology and data company, Azerion serves consumers, digital publishers, advertisers, and game creators globally. Azerion’s integrated platform provides technology solutions to automate the purchase and sale of digital advertising for media buyers and sellers, supported by in-market sales and campaign management teams. Through our technology, content creators, digital publishers and advertisers work with Azerion to reach the millions of people across the globe that play Azerion’s games and view its distributed entertainment content to increase engagement, loyalty, and drive e-commerce.

Founded in 2014 by two Dutch entrepreneurs, Azerion has experienced rapid expansion driven by organic growth and strategic acquisitions. Azerion is headquartered in Amsterdam, the Netherlands and is a publicly traded company listed on Euronext Amsterdam.

This press release contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

For more information visit: www.azerion.com

Investor Relations



The companies in which Azerion Group N.V. directly and indirectly owns investments are separate legal entities. In this announcement “Azerion”, “Azerion Group”, “Company” and “Group” are sometimes used for convenience where references are made to Azerion Group N.V. and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to Azerion Group N.V. and its subsidiaries in general or to those who work for them.

This press release is for information purposes only. The information contained in this press release does not purport to be full or complete and, in particular, is not intended to form the basis of any investment decision. No reliance may be placed by any person for any purpose on the information contained in this press release or its accuracy, fairness or completeness. Azerion will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided.

This press release may include forward-looking statements. All statements other than statements of historical facts may be forward-looking statements. Words and expressions such as believes, estimates, plans, projects, anticipates, expects, intends, may, will, should or other similar words or expressions are typically used to identify forward-looking statements. Forward-looking statements are subject to risks, uncertainties and other factors that are difficult to predict and that may cause the actual results of Azerion to differ materially from future results expressed or implied by such forward-looking statements. Any forward-looking statements reflect Azerion’s current views and assumptions based on information currently available to Azerion’s management. Forward-looking statements speak only as of the date they are made, and Azerion does not assume any obligation to update such statements, except as required by law. No assurances can be given that the forward-looking statements will be realised. No representation or warranty is made that any of these forward-looking statements will come to pass or that any estimated result will be achieved. Accordingly, no undue reliance should be placed on any forward-looking statements.

GlobeNewswire Distribution ID 1000797634

Political parties are prohibited from pulling institutions to campaign for votes.

Secretary of the EC sent a circular to notify political parties. Party members are prohibited from pulling institutions to campaign for votes. Ready to issue a letter warning the RRT not to let “Trirong” make another random speech

Sawaeng Bunmee, secretary-general of the Election Commission of Thailand (ECT), signed a letter on control and supervision requiring political party members to report violations of the law to all political party leaders. By stating that according to the 2017 Organic Act on Political Parties, Section 22 stipulates that the Executive Committee of political parties and executive committees have the duty to control and supervise members of political parties not to act in violation of the Constitution, laws, regulations, including regulations and announcements. and orders of the Election Commission

However, when there is a royal decree to elect MPs or elect senators, as the case may be. Political party executive committee and political party executive committee It has the duty to control and supervise members of political parties or political party holders from acting in a manner that may cause the election to be dishonest or fair. unlawful or may be against you or harm any person directly or indirectly

The political party registrar considered that for political parties to comply with the aforementioned laws Political parties therefore request that political party members comply with the constitution, laws, regulations, including regulations, announcements, and orders of the ECT, especially the ECT’s regulations on campaigning and prohibitions in electing members of the House of Representatives B.E. 2561. and an amendment in respect of the introduction of the monarchy in connection with election campaigns

When appearing to the Executive Committee of a political party or executive director of a political party or when the Executive Committee of a political party is notified by the Political Party Registrar that a member of a political party may act in violation of Section 22 paragraph one or paragraph two. The executive committee of the political party shall pass a resolution or order the member of the political party to immediately cease doing so. and prescribing necessary measures or means to prevent members of political parties from committing such acts again. Then notify the political party registrar within seven days from the date of resolution.

If the Executive Committee of a political party fails to comply with Section 22, paragraph three of the Organic Act on Political Parties B.E. The said order shall be published in the Government Gazette and prohibits the executive members of political parties who vacate office for such reasons from holding any position in a political party for 20 years from the date of retirement under section 22 paragraph four of the same Organic Act.

The secretary-general of the ECT signed a letter on the control and supervision of political party members for violating the law. Sent to the leader of the Ruam Thai Sang Chart Party With details about the fact that on February 25, 2023, Mr. Trirong Suwankhiri gave a speech in front of the Nakhon Ratchasima City Hall. During one of the speeches, the monarchy was used in election campaigns. which the political party registrar Considered that Mr. Trirong’s actions may violate the Election Commission’s regulations on campaigning and prohibited characteristics in the 2018 election of members of the House of Representatives and their amendments. Regarding the involvement of the monarchy in election campaigns He therefore asked the Ruam Thai Sang Nation Party to control and supervise Mr. Trairong from committing acts that may violate the constitution, laws, regulations, and regulations. announcements and orders of Election Commission.

Source: Thai News Agency

A look at the problem of cruelty to elephants on Thai Elephant Day

Thai Elephant Day this year In the midst of the drama after sharing images of elephant bones after collapsing from allowing tourists to sit on the elephant’s back for decades, and there are still many Thai elephants whose bones are deformed and deformed. causing the entrepreneurs of the elephant camp business for tourism to protest While elephant conservationists came out to demand that the government issue better measures to take care of the welfare of Thai elephants.

Source: Thai News Agency

Turning the farm to grow mangoes for sale Millions of annual income

Farmers at Ban Non Sa-at, Maha Sarakham Province have switched from farming 20,000 baht per year, amounting to 20 rai, to planting good varieties of mangoes. Sales earn more than a million baht per year.

Mrs La-Ong Sochan, a farmer at Ban Non Sa-at, Village No. 11, Bo Yai Subdistrict, Borabue District, Maha Sarakham Province, said that Borabue District has sandy soil and water shortage. Most of them grow crops that use less water, such as yam, cassava, but lately, farmers have suffered losses, the price has dropped, so they want to switch from growing cassava to planting perennial crops, starting from longan, rose apple, and Mayongchid, which are unsuccessful.

Until he came to plant a mango plantation at the persuasion of her husband from Nakhon Pathom. Started investing in digging artesian wells to make a drip irrigation system for 1,700 mango trees in the area of 20 rai of parents who used to grow cassava. by planting both the Nam Dok Mai Mango variety Keaw Sow, three flavors, and Mahachanok, Dawei breed, have been trial and error for a long time. fight until success Especially the big mangoes, beautiful skin, wholesale to middlemen at the Thai market and send to sell in big department stores, the price is 40 baht, come to pick up at the garden, while the premium grade produce is sold at the market at a price of hundreds of kilos. Buyers have high purchasing power. make the product sell at a higher price In addition, the mangoes at the orchard are certified by the GAP standard from the Department of Agriculture. Make consumers confident that the product is safe.

Over the past year, we collected more than 1.4 million baht in sales. This year, we aim to earn no less than last year’s mango sales. because of beautiful productivity More than 40 tons of mangoes are released in Dawei.

Source: Thai News Agency